Stock DNA
Information Technology Services
USD 576 Million (Micro Cap)
NA (Loss Making)
NA
92.37%
-0.03
-26.16%
1.84
Revenue and Profits:
Net Sales:
105 Million
(Quarterly Results - Nov 2024)
Net Profit:
-121 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
2.33%
0%
2.33%
6 Months
80.0%
0%
80.0%
1 Year
-26.88%
0%
-26.88%
2 Years
-48.31%
0%
-48.31%
3 Years
-54.45%
0%
-54.45%
4 Years
-85.12%
0%
-85.12%
5 Years
0%
0%
0.0%
Accolade, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
29.39%
EBIT Growth (5y)
-17.48%
EBIT to Interest (avg)
-67.50
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.03
Sales to Capital Employed (avg)
0.58
Tax Ratio
0.99%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
98.34%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.84
EV to EBIT
-6.59
EV to EBITDA
-13.44
EV to Capital Employed
1.86
EV to Sales
1.27
PEG Ratio
NA
Dividend Yield
92.37%
ROCE (Latest)
-28.26%
ROE (Latest)
-26.16%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Bearish
No Trend
OBV
Mildly Bearish
Mildly Bullish
Shareholding Snapshot : Nov 2024
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 45 Schemes (28.18%)
Foreign Institutions
Held by 87 Foreign Institutions (14.57%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Nov'24 - YoY
Nov'24
Nov'23
Change(%)
Net Sales
105.10
99.40
5.73%
Operating Profit (PBDIT) excl Other Income
-13.80
-20.50
32.68%
Interest
0.00
0.00
Exceptional Items
-98.50
9.40
-1,147.87%
Consolidate Net Profit
-121.30
-21.10
-474.88%
Operating Profit Margin (Excl OI)
-227.10%
-320.80%
9.37%
USD in Million.
Net Sales
YoY Growth in quarter ended Nov 2024 is 5.73% vs 9.35% in Nov 2023
Consolidated Net Profit
YoY Growth in quarter ended Nov 2024 is -474.88% vs 47.12% in Nov 2023
Annual Results Snapshot (Consolidated) - Feb'24
Feb'24
Feb'23
Change(%)
Net Sales
414.30
363.10
14.10%
Operating Profit (PBDIT) excl Other Income
-63.00
-108.10
41.72%
Interest
2.90
3.30
-12.12%
Exceptional Items
8.40
-308.00
102.73%
Consolidate Net Profit
-99.80
-459.60
78.29%
Operating Profit Margin (Excl OI)
-274.20%
-428.30%
15.41%
USD in Million.
Net Sales
YoY Growth in year ended Feb 2024 is 14.10% vs 17.13% in Feb 2023
Consolidated Net Profit
YoY Growth in year ended Feb 2024 is 78.29% vs -273.35% in Feb 2023
About Accolade, Inc. 
Accolade, Inc.
Information Technology Services
Accolade Inc. is a provider of personalized, technology-enabled solutions that helps people to understand, navigate, and utilize the healthcare system and their workplace benefits. The Company’s customers are primarily employers that deploy Accolade in order to provide employees and their families members a single place to turn for their health, healthcare, and benefits needs. Its platform combines open, cloud-based intelligent technology with multimodal support from a team of Accolade Health Assistants and clinicians (including nurses, physician medical directors, and behavioral health specialists). It leverages its integrated capabilities, connectivity with providers and the broader healthcare ecosystem, and longitudinal data to engage across the entire member population. The Company’s offerings are: Accolade Total Benefits, Accolade Total Care, Accolade Total Health and Benefits and Accolade Boost.
Company Coordinates 
Company Details
660 West Germantown Pike, Suite 500 , PLYMOUTH MEETING PA : 19462
Registrar Details






